STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

Summary

China has implemented tightened regulations on investigator-initiated trials, affecting both Chinese researchers and some American entities. The regulatory change comes as the U.S. seeks to accelerate its clinical trial processes to match China's speed.